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Abstract
We report the technique and outcome of percutaneous drainage 
and sclerotherapy as primary treatment of renal lymphangiomato-
sis. Between January and May 2009, two patients presenting with 
symptomatic renal lymphangiomatosis were treated in our depart-
ment by a minimally invasive modality combining percutaneous 
drainage with repeated sclerotherapy. We retrospectively analysed 
recurrence, complications and patient satisfaction. In this limited 
case series, percutaneous drainage and repeated sclerotherapy 
proved to be safe and effective for treating renal lymphangioma-
tosis. This procedure provides a minimally invasive option for 
selected patients, potentially avoiding a surgical procedure and 
any risk of complications.
Introduction 
Renal lymphangiomatosis (RL) is a rare developmental mal-
formation of the perirenal lymphatic system. It is due to 
the failure of the perirenal lymphatic tissue to form normal 
communications with the remainder of the lymphatic sys-
tem.1 This leads to the dilation of lymphatic vessels and to 
the formation of unilocular or multilocular cystic masses in 
the perirenal area. Confusion exists in the literature. Some 
authors refer to RL as renal lymphangiectasia.2 Thirty-six 
cases are described in the English literature.1,3-33 The dif-
ferential diagnosis includes adult polycystic renal disease, 
von Hippel-Lindau disease, tuberose sclerosis, renal lym-
phoma with perirenal involvement and nephroblastomato-
sis. Computed tomography (CT) and magnetic resonance 
imaging (MRI) play a key role in the diagnosis, as the find-
ings in RL are typical.15,17,19 In the absence of symptoms, 
conservative management is considered the best treatment; 
open or preferentially laparoscopic surgery is recommended 
to avoid recurrence in symptomatic patients.1,7 Percutaneous 
drainage has been proposed as an alternative when surgery 
is contraindicated, but it is not a definitive solution as it is 
followed by recurrence.3
We report the technique and outcome of percutaneous 
drainage and sclerotherapy as primary definitive treatment 
in two consecutive patients presenting with symptomatic RL.
Methods 
Two patients were referred to our department with right 
flank pain from January 2009 to May 2009. A CT and an 
MRI ruled out malignancy and suggested RL. Needle aspi-
ration confirmed the diagnosis. Treatment options, such as 
open or laparoscopic approach, percutaneous drainage or 
conservative management, were discussed. Finally, drain-
age and povidone-iodine sclerosis were chosen based on 
the patients’ previous lymphocele treatment on the basis of 
previous description of lymphocele treatment.34 A percuta-
neous drainage catheter (Flexima All Purpose Drain, Boston 
Scientific, Natick, MA) was placed using a trocar technique 
under ultrasound guidance. Intralesional aministration of 
50 mL povidone-iodine 11 mg/mL (Betadine, Mundipharma, 
Hamilton, Bermuda) was injected twice daily through the 
catheter. Following the previously described technique of 
lymphocele sclerosis, the injected povidone-iodine was left 
in place in the cysts for 30 minutes. Afterwards, the drain 
was unclamped and the fluid flowed out freely. The drain 
was left in place until the daily volume of discharge was 
less than 30 mL; then, it was removed. 
Patients were closely followed up clinically and with 
renal function measurement and CT scan. Disease recur-
rence, complications and patient satisfaction were assessed 
at follow-up to quantify the outcome of this procedure.
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Results 
Case 1 
In January 2009, an 87-year-old man was referred to our 
hospital with right flank pain. The patient had significant 
medical morbidity: stenosis of the superior mesenteric artery, 
atrial fibrillation and severe coronary heart disease. For these 
reasons, he was anticoagulated and treated with antiplatelet 
drug. Physical examination and biochemical investigations 
were normal. A CT scan revealed moderate right renal pel-
viceal dilation and bilateral subcapsular hypodense lesions 
in the perinephric region within Gerota’s fascia compatible 
with RL. An MRI confirmed the diagnosis (Fig. 1). Needle 
aspiration revealed a chylous content with a high content of 
lymphocytes and macrophages. Creatinine concentration in 
the fluid was similar to serum levels. A right ureteral pigtail 
catheter was introduced to relieve pain owing to renal dila-
tion. Two months later, the patient developed heart failure 
due to compression of the great vessels by the right multi-
cystic mass (Fig. 2). 
Surgical treatment was not possible because of the 
patient’s general condition, and so percutaneous drainage 
and sclerotherapy with a 10F catheter was carried out for 21 
days. The clinical result was excellent after the evacuation 
of 5 L of fluid. Pressure on the great vessels was completely 
relieved. No complication was noted during the hospital 
stay and at follow-up 2 months later; a CT-scan revealed no 
recurrence with normal renal function (Fig. 3). There was a 
complete relief of right flank pain and total patient satisfac-
tion. The patient died 4 months after the drainage of acute 
myocardial infarction unrelated to the procedure.
Case 2 
In May 2009, a 47-year-old man with no significant medical 
or family history presented with right flank pain. Physical and 
biochemical examination were normal. A CT scan showed 
right perirenal multilocular fluid-filled masses, with anterior-
medial displacement of the right kidney (Fig. 4). The kidneys 
excreted contrast normally. An MRI revealed hyperintensive 
renal subcapsular lesions on T2-weighted compatible with 
RL. A high content of lymphocytes with normal creatinine 
value was found in the perinephric fluid obtained by needle 
aspiration. The patient underwent percutaneous drainage 
and sclerotherapy with an 8F catheter. Daily povidone-
iodine washing was performed for 18 days. The result was 
again excellent and no complication was recorded at each 
follow-up. Renal function remained normal. A CT-scan at 1, 
3, 9 and 15 months showed no relapse of the lesions (Fig. 
5). Right flank pain completely disappeared and the patient 
had no discomfort.
Discussion 
RL is a rare benign condition with no gender or age predilec-
tion. It can be either unilateral or bilateral.4,5 It is common-
ly sporadic, but hereditary cases have been described.6,31 
Reported symptoms are non-specific, such as hematuria, 
abdominal pain and ipsilateral flank pain. Nevertheless, 
most patients remain asymptomatic and this anomaly is usu-
Fig. 1. Coronal T2-weighted magnetic resonance imaging shows bilateral renal 
multilocular hyperintense subcapsular lesions. These findings are typical of 
renal lymphangiomatosis. 
Fig. 2. Contrast enhanced computed tomography scan shows bilateral renal 
subcapsular hypodense lesions in the perinephric region within the Gerota’s 
fascia compressing the right kidney and inferior vein cava.
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ally detected incidentally on abdominal imaging performed 
for other reasons. Physical examination rarely reveals a pal-
pable mass. Biochemical examination and renal function are 
usually normal. Complications, such as renal vein thrombo-
sis, obstructive uropathy and renal hypertension, have been 
reported.4 Our first patient represents a rare association of 
heart failure in relation with RL. 
A CT scan and MRI images are pathognomonic of the 
disease. On CT, perinephric lesions appear well-delineated 
with surrounding structures often displaced, but not invad-
ed.15,17 Cyst attenuation lies in the range of water. An MRI 
typically shows the cysts as hypointense on T1-weighted 
images and hyperintense on T2 weighted images.19 Needle 
aspiration of the perirenal collections can confirm the diag-
nosis since chylous content with lymphocytes, protein and 
fat is typical of RL.4,15
As of January 2011, there are 36 patients reported in 
literature (Table 1). Asymptomatic patients do not need 
treatment since the disease is benign and rarely leads to 
complications. However, depending on the patient’s specific 
condition, symptomatic cases should be treated because the 
lesions rarely regress spontaneously. An open or laparo-
scopic approach with cyst marsupialisation or ablation of 
perirenal cysts is feasible.1 However, surgery can be hard 
to perform depending on the size and location of the cysts. 
Lesions in the renal hilum can be difficult to isolate and 
nephrectomy may have to be necessary. Lack of data in 
literature makes a comparison in functional outcome by dif-
ferent surgical techniques impossible. Symptomatic patients 
who were not eligible for surgery have thus far been treated 
by percutaneous drainage.3 This type of procedure is easy 
to perform, but only temporarily successful. It cannot be 
considered a therapeutic solution because it is inevitably 
followed by recurrence. Unfortunately, since the disease 
is rare, it can be mistaken for a malignant lesion and some 
patients are overtreated by nephrectomy.6,12,20,25,27 
For our two patients, we preferred a minimally invasive 
modality combining percutaneous drainage with repeated 
long-acting sclerotherapy until total regression of the cysts 
was demonstrated. As in RL, the dilated lymphatic vessels 
are around the kidneys and within the renal sinus forming 
multiloculated cavities To favour a homogeneous sclerosing 
agent distribution and to avoid strictures on excretory system, 
Fig. 3. Unenhanced computed tomography scan 2 months after the 
percutaneous drainage and sclerotherapy shows no recurrence. Observe the 
hyperdense rim around the right kidney related to povidone-iodine deposition 
on the wall of the cystic cavities (arrow). Contralateral fluid collections have 
also regressed. This confirms that there was a communication between the 
two perirenal masses.
Table 1. Treatment in reported cases of renal 
lymphangiomatosis
Reference in 
this article
Year of 
publication
Treatment
1 2007
Patient 1: Laparoscopic excision  
Patient 2: Conservative
2 2001 Percutaneous drainage
3 2009 Conservative
4 2003 Conservative
5 1988
Patient 1: Nephrectomy  
Patient 2: Conservative
6 2007 Conservative
7 2004 Open excision
8 2011 Conservative
9 1998 Conservative
10 2010 Percutaneous drainage
11 2009 Nephrectomy
12 2008 Conservative
13 2008 Percutaneous drainage
14 2008 Pateint 1 & 2: Conservative
15 2007 Conservative
16 2007 Conservative
17 2006 Conservative
18 2005 Conservative
19 2004 Nephrectomy
20 2002 Conservative
21 2001 Conservative
22 2000 Conservative
23 1997 Conservative
24 1997 Nephrectomy
25 1995 Percutaneous drainage
26 1992 Nephrectomy
27 1987 Conservative
28 1970 Conservative
29 2010 Conservative
30 2010 Patient 1 & 2: Conservative
31 2010 Conservative
32 2006 Conservative
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we chose a long-acting agent (i.e., povidone-iodine) rather 
than alcohol. Povidone-iodine is also far cheaper than other 
agents (i.e., doxycycline). 
Our patients supported the treatment well and had no 
procedural or postoperative complications. Follow-up CT 
showed no recurrence. 
Conclusion 
Our limited case series shows that this technique is safe and 
efficient. Larger series are needed to confirm these findings. 
Unfortunately, since the disease is rare and sometimes mis-
understood, it is difficult to collect many cases. Nevertheless, 
we recommend this procedure as a first-line treatment in 
symptomatic patients presenting with RL to reduce morbidity 
and avoid surgical complications.
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